Expert review of anticancer therapy
Pretreatment hyperferritinaemia as an independent prognostic marker in metastatic solid tumors treated with immune checkpoint inhibitors.
Fatma Pinar Açar, Caner Acar, Haydar Çağatay Yüksel, Gökhan Şahin, Burçak Karaca
Published: 202510.1080/14737140.2025.2602806
Abstract
BACKGROUND: Hyperferritinaemia is common in cancer and may reflect tumor-associated macrophage activity and ferroptosis resistance, yet its prognostic value during immune checkpoint inhibitor (ICI) therapy is uncertain. METHODS: We retrospectively an…
Preview only. Read the full abstract at the source